On February 17, 2026, EVR Research disclosed a new position in Ingevity (NYSE:NGVT), acquiring 100,000 shares worth $5.92 million. What happened In a U.S. Securities and Exchange Commission (SEC) filing dated February 17, 2026, EVR Research reported initiating a new position in Ingevity by purchasing 100,000 shares during the fourth quarter. The fund's quarter-end position in NGVT was valued at $5.92 million, reflecting the full size of the new stake. What else to know This was a new position for the ...